CEVERTEC
ActiveSummary
CEVERTEC has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €396,989 and a net result of €85,198. Equity is growing by about 9.2% per year across the filed financial years. Its solvency ranks better than 66% of 34,143 sector peers (NACE 43, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
17-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
20-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Highest result from 2019 to 2025net €88,393 ▲31.7%
Operating result €130,148, net result €88,393, both a record.
11-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
13-06
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial
Equity above €200,000equity €212,205 ▲7.7%
A profit in every financial year since 2019 builds equity to €212,205.
17-10
NBB filing
Annual accounts filed
financial year 2021 · micro format · 78 days late
2021
22-03
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
30-09
Financial
Weakest financial yearnet €8,927 ▼39.5%
Net result drops to €8,927, the lowest in the series; recovery starts the following year.
25-03
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
19-03
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
19-03
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
23-03
NBB filing
Annual accounts filed
financial year 2016 · full format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 24 annual accounts filed, the latest 10 are here; all 24 are under Financials.
0 of 3 deeds read
About the unread acts
We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.